NCT07511621 A Multi-Level Strategy for De-implementing Mammography Overuse Among Older Women
| NCT ID | NCT07511621 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Columbia University |
| Condition | Mammography |
| Study Type | INTERVENTIONAL |
| Enrollment | 500 participants |
| Start Date | 2026-03-11 |
| Primary Completion | 2028-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 500 participants in total. It began in 2026-03-11 with a primary completion date of 2028-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project aims to advance methodological and theoretical approaches for developing, selecting, refining, and piloting a multilevel de-implementation strategy to reduce the overuse of screening mammography in women aged ≥75 years. Informed by an innovative participatory, stakeholder-driven innovation tournament and a discrete choice experiment, the research team identified, prioritized, and tailored a multilevel de-implementation strategy. The research team will conduct a cluster randomized controlled trial (at the provider level) to test the impact of the provider- and patient-level components of the multilevel strategy on screening mammography use, and secondarily, on provider referrals/orders for screening mammography. The organizational level components of the multilevel strategy will be implemented among all participants, not via random assignment.
Eligibility Criteria
Patient level criteria Inclusion criteria * English- or Spanish-speaking women based on preferred language in electronic health record * Aged 75 and older at the time of their scheduled primary care visit * Women who have a primary care visit scheduled within the next 2-4 weeks * Women who have not had a screening mammogram 6 months prior to their scheduled primary care visit but have had a screening mammogram 7-18 months prior to their scheduled primary care visit Exclusion Criteria * Women with a history of atypical ductal hyperplasia (ADH) or non-invasive or invasive breast cancer (assessed via ICD 10 code) * Women with dementia (assessed via ICD 10 code) * ICD codes to use across exclusion criteria: F01-F03, Z85.3, G30-G31, N60, C50, or D05 Provider level criteria Inclusion Criteria • Primary care clinicians attributed to the 2 intervention clinics that serve adult patients, including those ≥75 years Exclusion Criteria * Specialists * Primary care clinicians for patients \< 18 years old * Non-clinicians * Physician assistants
Contact & Investigator
Parisa Tehranifar, DrPH
PRINCIPAL INVESTIGATOR
Columbia University
Frequently Asked Questions
Who can join the NCT07511621 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Mammography. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07511621 currently recruiting?
Yes, NCT07511621 is actively recruiting participants. Contact the research team at pt140@cumc.columbia.edu for enrollment information.
Where is the NCT07511621 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT07511621 clinical trial?
NCT07511621 is sponsored by Columbia University. The principal investigator is Parisa Tehranifar, DrPH at Columbia University. The trial plans to enroll 500 participants.